Docket #: S16-409
Methods to promote bone healing in patients with diabetes
Researchers at Stanford have developed methods to promote bone healing in people with diabetes. Diabetes is a chronic metabolic disease associated with many clinical complications including impaired bone healing. In fact, poor fracture healing is a major cause of morbidity in diabetic patients and a growing medical problem worldwide. Therefore, it is of great clinical interest to develop therapeutics to restore bone healing. To help meet this need, the inventors have taken advantage of their recent work. They have discovered that hedgehog signaling is deficient in skeletal stem cells in diabetic patients. This leads to impaired fracture healing. With this technology, they have developed methods of administering a hedgehog agent at the injury site to reverse these deficiencies and enhance bone regeneration. This method provides the potential to improve bone healing in diabetic patients.
Stage of research
Using diabetic mouse models, the inventors have shown that administering a hedgehog agent to the fracture rescued bone healing.
Applications
- Potential therapeutic to promote bone healing in diabetic patients for:
- Skeletal fracture repair
- Securing bone implants
- Securing teeth implants
Advantages
- Solves an unmet need: provides a potential therapeutic to promote bone healing/regeneration in diabetic patients
- Deficiency is specific to diabetic skeletal fractures
Publications
- Tevlin R, Seo EY, Marecic O, McArdle A, Tong X, Zimdahl B, Malkovskiy A, Sinha R, Gulati G, Li X, Wearda T, Morganti R, Lopez M, Ransom RC, Duldulao CR, Rodrigues M, Nguyen A, Januszyk M, Maan Z, Paik K, Yapa KS, Rajadas J, Wan DC, Gurtner GC, Snyder M, Beachy PA, Yang F, Goodman SB, Weissman IL, Chan CK, and MT Longaker. Pharmacological rescue of diabetic skeletal stem cell niches. Science Translational Medicine, 11 Jan 2017. Vol. 9, Issue 372. DOI: 10.1126/scitranslmed.aag2809.
- Conger, K. Diabetes impairs activity of bone stem cells in mice, inhibits fracture repair. Stanford News. 11 Jan 2017.
- WO/2018/129470
Related Links
Patents
- Published Application: WO2018129470
- Published Application: 20190336575
- Issued: 11,529,391 (USA)
Similar Technologies
-
Collagen Materials, Films and Methods S08-229Collagen Materials, Films and Methods
-
Tissue engineering scaffold with controllable macropore-formation S12-148Tissue engineering scaffold with controllable macropore-formation
-
Proliferative vitreoretinopathy (PVR) therapy with growth and differentiation factor 15 (GDF15) S20-427Proliferative vitreoretinopathy (PVR) therapy with growth and differentiation factor 15 (GDF15)